NCT03460704: A trial that was reported late by Zambon SpA
This trial has reported, although it was 271 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03460704 |
|---|---|
| Title | Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in Subjects With Non-cystic Fibrosis Bronchiectasis Chronically Infected With P. Aeruginosa |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 29, 2018 |
| Completion date | March 15, 2022 |
| Required reporting date | March 15, 2023, midnight |
| Actual reporting date | Dec. 11, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 271 |